2-(4-phenoxyphenyl)-7-(1-(3-(4-(3-carbamoyl-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl)-3-oxopropyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
Zanubrutinib Impurity 5 is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Buy 2190506-55-7 Purchase 2190506-55-7 Order 2190506-55-7 Enquire 2190506-55-7 2190506-55-7 price 2190506-55-7 supplier 2190506-55-7 manufacturer 2190506-55-7 exporter Zanubrutinib Impurity 5 for method validation Zanubrutinib Impurity 5 reference standard Zanubrutinib Impurity 5 for ANDA filing Zanubrutinib Impurity 5 for forced degradation studies Zanubrutinib Impurity 5 identification standard Zanubrutinib Impurity 5 for DMF filing Zanubrutinib Impurity 5 HPLC standard Zanubrutinib Impurity 5 supplier Zanubrutinib Impurity 5 manufacturer Zanubrutinib Impurity 5 distributor
